Editing Paul Norggohole (section)

== Snubable Enterprise ==
While finishing his doctorate, Norggohole attended a biotechnology event in Switzerland through an NTNU industry contact. At a later scientific and industrial reception linked to the [[World Economic Order]], [[Stefan Shrankenhaus]] questioned him about reprogramming differentiated cells and maintaining stable cell lines. Shrankenhaus arranged a highly paid consultancy assignment in Romania through a WEO-linked company, but the offer did not identify Snubable Enterprise. Norggohole travelled to Romania expecting a short biotechnology assignment. At Snubable's main complex in [[Căciulați]], he was shown abnormal cell cultures and restricted production areas before learning that the facility manufactured human clones. He accepted permanent employment soon afterward. [[Richard Rambam]] separately paid him €1 million to keep Snubable's work secret, and on 1 October 2010 Norggohole joined as a senior cellular-reprogramming researcher reporting directly to Rambam.

Soon after joining Snubable, Norggohole separated preserved master stocks from the working cultures used for clone manufacture. He tightened culture-history controls around that separation, with contamination screening before reprogrammed material entered production. Gene-expression screening was added to the same process. Snubable began routine whole-transcriptome monitoring for ischemic stress in 2011.<ref name="clone-production"/> Norggohole designed the screening used to compare developing material with established A-Series reference patterns. Rambam appointed him Head of Developmental Cell Biology on 15 March 2011. Staff later called him "Professor Norggohole" inside Snubable, although he did not hold a university professorship. His department handled reprogramming before production and maintained the master cell banks.<ref name="clone-production"/> [[Sorin Spitt]] examined clones after incubation and handled pathology and medical assessment.

The [[R-Series]] entered development in 2011 using [[Rasmus Rogganoid]] as its genetic source.<ref name="r-series"/> Norggohole opposed routine production because he believed there was not enough evidence that Rogganoid-derived cells would remain stable under accelerated maturation. He warned Rambam in writing that the line was not ready. Rambam ordered production to continue, leaving Norggohole to screen the batches and reject those showing the most severe developmental instability. Later that year, an unstable clone attacked him during an examination and security personnel failed to restrain it. Norggohole took a steel fire extinguisher from nearby and struck the clone repeatedly until it stopped moving. [[Jibbut Snagov]] arrived with security personnel and shot it in the head before the body was sent for the post-mortem examination required by Spitt. Norggohole stopped objecting to the routine termination of failed clones after the attack and treated it as part of production control.

In 2013, Norggohole set a developmental threshold too tightly, causing approximately 150 to 200 viable clones to be classified as failures and terminated before the mistake was found. Rambam ordered him to recalibrate the screening system but left him in charge of the department. A culture-contamination incident the following year kept Norggohole in the affected laboratory for almost a full day while staff isolated threatened cell banks. He refused to leave until the master stocks were secured, then collapsed from exhaustion. Spitt treated him with fluids and kept him under observation in the medical section. From 2015, Norggohole also screened Tanoan-supplied culture media and laboratory material before it entered Snubable research.

Norggohole knowingly participated in [[Aktion Shrankenhaus]] in 2017. He used developmental records to identify clones he believed were most likely to withstand combat, while Spitt performed the medical screening before deployment. Norggohole knew they were being sent to [[Slatina]] and that civilians would be killed. He travelled to the staging site outside the city and remained there during the attack, where he monitored the condition of deployed clones. As losses increased, he helped decide which reserve units were stable enough to be sent into Slatina. The deployment caused the [[2017 Slatina massacre]], in which an estimated 34,000 to 40,000 people were killed.<ref name="aktion"/> Norggohole drank heavily for several days after returning to Căciulați before he resumed work.

In 2020, Rambam developed a severe toothache and asked Norggohole to arrange treatment. Norggohole contacted his cousin [[Ben Norggohole]], then a dentist in Tromsø, and told him that a wealthy Romanian employer needed urgent dental care. He did not tell Ben about Snubable or its cloning programme. Paul collected him in Bucharest and drove him to Căciulați, where Ben discovered what the facility was and confronted him. Paul apologized for deceiving him but maintained that Ben probably would not have travelled to Romania if he had been told beforehand. After Ben treated Rambam, Rambam offered him €30,000 to remain in Romania as Snubable's dentist.<ref name="ben-career"/> Paul encouraged him to accept. Paul visited Ben regularly at his Bucharest home in the years that followed.<ref name="ben-career"/> He warned Ben away from parts of Snubable where he believed he could be endangered.

The arrival of the Borvă specimen UB-01 in 2021 brought Norggohole into [[Project Umbrar]].<ref name="experimental-research"/> He worked on combining human and Borvă biological material during development, while Spitt directed medical assessment of the resulting bodies. Norggohole concluded that incomplete cellular reprogramming was the main reason the experiments failed. Development could begin from both biological sources, but their cellular programmes did not reset cleanly enough to produce a stable organism. The repeated failures also affected his conduct in the laboratory. During one failed run, he shouted at staff for repeating procedures incorrectly and swept an instrument tray onto the floor. He then ordered the work restarted. Rambam did not discipline him. Project Umbrar ended on 3 November 2022.<ref name="experimental-research"/>

By 2023, Norggohole was regularly using cocaine during long periods of laboratory work and was also drinking alcohol. His cocaine use had developed into a binge pattern by 2024, with periods of several days without use followed by large amounts during work-related stress. At the same time, Rambam had begun the B-Series stabilization project using archived early A-Series stock. Norggohole rebuilt the cell banks from the archived stock. He screened the resulting material as it matured, concentrating on developmental stability. By 2024, he believed the archived stock had corrected some earlier defects, but incomplete microvascular maturation remained. He repeatedly warned Rambam that the programme was moving faster than the biology supported. Rambam refused to slow it, and the B-Series never entered industrial production before Snubable collapsed.<ref name="clone-production"/>